videoSlug

VideoSlug_VideoQuery

slug

VideoPageContentQuery

content

videos

query VideoSlug_VideoQuery(
  $videoSlug: String!
) {
  ...VideoPageContentQuery_1X4EH4
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment LatestVideos_Videos on Query {
  videos(first: 5, upcoming: false, order: {field: liveTime, direction: DESC}) {
    edges {
      node {
        id
        title
        lang
        pageUrl
        liveTime
        isLive
        companies {
          name
          squareLogoUrl
          id
        }
      }
    }
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment VideoPageContentQuery_1X4EH4 on Query {
  content(slug: $videoSlug, type: [VIDEO, WEBCAST]) {
    __typename
    id
    title
    slug
    lang
    htmlBody
    companies {
      viewerIsFollowing
      id
      name
      pageUrl
      defaultInstrument {
        id
        isin
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    createdAt
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    ... on Video {
      imgUrl
      videoEmbedUrl(location: "inderes")
      audioEmbedUrl
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ... on Webcast {
      imgUrl
      videoEmbedUrl(location: "inderes")
      registrationInfoHtml
      registrationUrl
      liveTime
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
  }
  ...LatestVideos_Videos
}


type

__typename

title

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

first

order

upcoming

edges

ExpreS2ion Biotech Holding

ExpreS2ion Biotechnologies is expected to release its Q4 2024 results on 6 February 2025. On the same day at 10:00, the company’s and CFO Keith Alexander will present the results and the achievements in an online live presentation. The management presentation will be followed by a Q&A session.

You can already now sign up for the event and send in your questions. You don&#x2019;t have to participate live to submit your questions for the event. ExpreS2ion Biotechnologies is expected to release its Q4 2024 results on 6 February 2025. On the same day at 10:00, the company&#x2019;s and CFO Keith Alexander will present the results and the achievements in an online live presentation. The management presentation will be followed by a Q&amp;A session. Besides the financial results for the last quarter of 2024, other focus areas of the presentation could be the capital situation after the latest funding round as well as an update on the news flow since the Q3 2024 report. In early December, the Austrian Agency for Health and Food Safety approved the phase I clinical trial application (CTA) for the breast cancer candidate. ExpreS2ion Biotechnologies is a Danish pharmaceutical company, which focuses on the development of vaccines through the use of its non-viral Drosophila S2 cells-based expression system. Disclaimer: HC Andersen Capital receives payment from ExpreS2ion Biotechnologies for a Digital IR/Corporate Visibility subscription agreement. /Michael Friis, 13.11 10 January 2025.

HC Andersen Capital

ExpreS2ion Biotechnologies - Presentation of Q4 2024

Incap

Incap India’s production and testing director interviewed

AKTIER MED FRIIS - UGE 46 2025

Nibe Industrier

NIBE, Audiocast, Q3'25

Egetis Therapeutics

Egetis Therapeutics, Audiocast, 2025

Novo Nordisk

Bavarian Nordic

SKAKO

BioPorto

Vestas Wind Systems

Zealand Pharma

Ørsted

Royal Unibrew

HCA Morgenbørs 14/11 - Overvejende negative markeder og fokus på Bavarian Nordic

ExpreS2ion Biotechnologies - Presentation of Q4 2024

ExpreS2ion Biotech Holding

Recent videos

Privacy preferences